2m 2m 2m 2m 2m 2m 2m
Biocryst Pharm (BCRX)
NASDAQ
$7.62+$0.08 (+1.13%)
Price as of Nov 11, 2026 7:50 PM EST- $1.9BMarket Cap
- 4.15%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
Biocryst Pharm (BCRX)
$7.62+$0.08 (+1.13%)
BCRX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $7.53 | ||
Change | -$0.10 (-1.31%) | ||
Open | $7.57 | ||
High | $7.70 | ||
Low | $7.46 | ||
Previous Close | $7.63 | ||
Volume | 4,047,051 | ||
30-Day Average Volume | 5,861,581 | ||
1-Week Change | -12.14% | ||
1-Month Change | -11.93% | ||
1-Year Change | 4.15% | ||
3-Year Change | 51.20% | ||
5-Year Change | -40.85% | ||
Fundamentals | |||
Shares Outstanding | 257.3M | ||
Total Assets | $591.1M | ||
Market Cap | $1.9B | ||
Enterprise Value | $2.2B | ||
Period: QTR TTM FY | |||
Revenue | $172.3M | ||
Net Income | $37.9M | ||
Free Cash Flow | $32.8M | ||
EBIT | $47.0M | ||
EBITDA | $47.0M | ||
Net Working Capital | $335.3M | ||
EPS | $0.14 | ||
Enterprise Value/EBITDA | 48 | ||
Enterprise Value/Revenue | 13 | ||
P/B | -5 | ||
P/E | 54 | ||
PEG | -1 | ||
Price/Free Cash Flow | 59 | ||
Price/Operating Cash Flow | 59 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue